Comparative prognostic performance of staging systems for hepatocellular carcinoma: Evidence from a Vietnamese cohort study

Figure 4 Calibration plots evaluating the predictive accuracy of seven staging and scoring systems for hepatocellular carcinoma prognosis. A and B: Barcelona clinic liver cancer staging system; C and D: Hong Kong Liver Cancer (HKLC) staging system (9-tier); E and F: HKLC staging system (5-tier); G and H: Cancer of the Liver Italian Program score; I and J: Italian Liver Cancer staging system; K and L: Japan Integrated staging score; M and N: Tokyo score for hepatocellular carcinoma; O and P: Model to estimate survival in ambulatory hepatocellular carcinoma patients; A, C, E, G, I, K, M and O: At 12 months; B, D, F, H, J, L, N and P: At 36 months. BCLC: Barcelona Clinic Liver Cancer; HKLC: Hong Kong Liver Cancer; CLIP: Cancer of the Liver Italian program; ITA.LI.CA: Italian Liver Cancer; JIS: Japan Integrated staging; MESIAH: Model to estimate survival in ambulatory hepatocellular carcinoma patients.